Kumar Pallav1,2, Hua Xu1, Daniel A Leffler1, Toufic Kabbani1, Ciaran P Kelly1. 1. Celiac Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. 2. Division of Digestive Diseases, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Abstract
BACKGROUND AND AIMS: Multiple European studies report increased prevalence of selective immunoglobulin A deficiency (SIgAD) and partial immunoglobulin A deficiency (PIgAD) in patients with celiac disease (CD). However; prospective data representing North American adults are lacking. While SIgAD precludes the use of IgA-tissue-transglutaminase antibody (IgA-tTG), the effect of PIgAD on IgA-tTG sensitivity is not well documented. We aim to determine the prevalence and impact of IgA deficiency on CD presentation and diagnosis in North American adult patients. METHODS: We reviewed 1000 consecutive patients undergoing IgA-tTG testing and 243 healthy controls. Eligible sera were tested for IgA-tTG, serum immunoglobulins, and IgA/IgG-deamidated gliadin peptide (IgA/IgG-DGP). RESULTS: Prevalence of SIgAD was marginally higher in patients with CD (1.9%) compared with healthy controls (0.4%, P = 0.24) and patients without CD (0.7%, P = 0.173). Prevalence of PIGAD was similar in patients with CD (4.8%) compared with healthy controls (5.9%, P = 0.57) and patients without CD (7.2%, P = 0.22). One (16.7%) of 6 patients with CD with SIgAD and all 15 (100%) with PIGAD tested IgA-tTG positive prior to gluten-free diet initiation. Patients with CD with SIGAD showed lower frequency of gastrointestinal symptoms (33% vs 82%, P = 0.01) and more co-morbid autoimmune disease (67% vs 23%, P = 0.03) when compared with patients with CD with normal IgA. CONCLUSIONS: The prevalence of SIgAD in North American patients with CD is comparable with European data but not significantly different than control populations. Patients with CD with SIgAD exhibit decreased IgA-tTG sensitivity and lack of gastrointestinal symptoms. PIgAD is common in patients with gastrointestinal disorders but does not alter CD presentation or IgA-tTG sensitivity.
BACKGROUND AND AIMS: Multiple European studies report increased prevalence of selective immunoglobulin A deficiency (SIgAD) and partial immunoglobulin A deficiency (PIgAD) in patients with celiac disease (CD). However; prospective data representing North American adults are lacking. While SIgAD precludes the use of IgA-tissue-transglutaminase antibody (IgA-tTG), the effect of PIgAD on IgA-tTG sensitivity is not well documented. We aim to determine the prevalence and impact of IgA deficiency on CD presentation and diagnosis in North American adult patients. METHODS: We reviewed 1000 consecutive patients undergoing IgA-tTG testing and 243 healthy controls. Eligible sera were tested for IgA-tTG, serum immunoglobulins, and IgA/IgG-deamidated gliadin peptide (IgA/IgG-DGP). RESULTS: Prevalence of SIgAD was marginally higher in patients with CD (1.9%) compared with healthy controls (0.4%, P = 0.24) and patients without CD (0.7%, P = 0.173). Prevalence of PIGAD was similar in patients with CD (4.8%) compared with healthy controls (5.9%, P = 0.57) and patients without CD (7.2%, P = 0.22). One (16.7%) of 6 patients with CD with SIgAD and all 15 (100%) with PIGAD tested IgA-tTG positive prior to gluten-free diet initiation. Patients with CD with SIGAD showed lower frequency of gastrointestinal symptoms (33% vs 82%, P = 0.01) and more co-morbid autoimmune disease (67% vs 23%, P = 0.03) when compared with patients with CD with normal IgA. CONCLUSIONS: The prevalence of SIgAD in North American patients with CD is comparable with European data but not significantly different than control populations. Patients with CD with SIgAD exhibit decreased IgA-tTG sensitivity and lack of gastrointestinal symptoms. PIgAD is common in patients with gastrointestinal disorders but does not alter CD presentation or IgA-tTG sensitivity.
Authors: T Not; A Tommasini; G Tonini; E Buratti; M Pocecco; C Tortul; M Valussi; G Crichiutti; I Berti; C Trevisiol; E Azzoni; E Neri; G Torre; S Martelossi; M Soban; A Lenhardt; L Cattin; A Ventura Journal: Diabetologia Date: 2001-02 Impact factor: 10.122
Authors: Daniel Leffler; Detlef Schuppan; Kumar Pallav; Robert Najarian; Jeffery D Goldsmith; Joshua Hansen; Toufic Kabbani; Melinda Dennis; Ciarán P Kelly Journal: Gut Date: 2012-05-22 Impact factor: 23.059
Authors: Danilo Villalta; Elio Tonutti; Christian Prause; Sibylle Koletzko; H Holm Uhlig; Pieter Vermeersch; Xavier Bossuyt; Martin Stern; Martin W Laass; Julia H Ellis; Paul J Ciclitira; Thomas Richter; Cornelia Daehnrich; Wolfgang Schlumberger; Thomas Mothes Journal: Clin Chem Date: 2009-12-18 Impact factor: 8.327
Authors: Cristina M A Jacob; Antonio C Pastorino; Kristine Fahl; Magda Carneiro-Sampaio; Renato C Monteiro Journal: J Clin Immunol Date: 2008-01-17 Impact factor: 8.317
Authors: Raif S Geha; Luigi D Notarangelo; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Alain Fischer; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Jennifer M Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood Journal: J Allergy Clin Immunol Date: 2007-10 Impact factor: 10.793
Authors: I R Korponay-Szabó; I Dahlbom; K Laurila; S Koskinen; N Woolley; J Partanen; J B Kovács; M Mäki; T Hansson Journal: Gut Date: 2003-11 Impact factor: 23.059
Authors: Marisa G Stahl; Cristy Geno Rasmussen; Fran Dong; Kathleen Waugh; Jill M Norris; Judith Baxter; Liping Yu; Andrea K Steck; Brigitte I Frohnert; Edwin Liu; Marian J Rewers Journal: Am J Gastroenterol Date: 2021-01-01 Impact factor: 12.045
Authors: Ida Judyta Malesza; Michał Malesza; Iwona Krela-Kaźmierczak; Aleksandra Zielińska; Eliana B Souto; Agnieszka Dobrowolska; Piotr Eder Journal: Int J Mol Sci Date: 2020-07-23 Impact factor: 5.923
Authors: Irma J A de Bruin; Lisanne Vranken; Caroline E Wyers; Robert Y van der Velde; Thera A M Trienekens; Sjoerd Kaarsemaker; Heinrich M J Janzing; Frank L Wolters; Siep Wouda; Piet P M M Geusens; Joop P W van den Bergh Journal: Calcif Tissue Int Date: 2020-07-28 Impact factor: 4.333
Authors: Nikolai A Kolchak; Maria K Tetarnikova; Maria S Theodoropoulou; Alexandra P Michalopoulou; Demetrios S Theodoropoulos Journal: J Multidiscip Healthc Date: 2017-12-27